ReviewClinical pharmacology and therapeutics2020

Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence.

Krishna Sriram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.